<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01300416</url>
  </required_header>
  <id_info>
    <org_study_id>CERL080AMY02</org_study_id>
    <nct_id>NCT01300416</nct_id>
  </id_info>
  <brief_title>Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms</brief_title>
  <acronym>PROGIS</acronym>
  <official_title>Open, Multi-centre, Non-interventional, Observational Study to Characterize the Impact That GI Complaints Have on Patient-reported Outcomes in Patients Who Have Had a Renal Transplant. Patients Will be Evaluated at Visit 1 and Then Again After 4 (+2) Weeks (Visit 2)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will access the GI complaints on patients reported outcomes and to determine the
      improvement in quality of life in patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To determine if GI symptoms severity and health related quality of life of patients has improved after being converted from MMF to EC-MPS due to GI complaints.</measure>
    <time_frame>4-6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To identify and evaluate quality of life and impact on symptom severity based on patients perception.</measure>
    <time_frame>4-6 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">101</enrollment>
  <condition>Kidney Transplantation</condition>
  <condition>GI Symptoms Severity</condition>
  <arm_group>
    <arm_group_label>With Gastro-Intestinal (GI) symptoms</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Without GI symptoms</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Kidney transplanted Patients currently on MMF who have GI symptoms and will be converted to
        EC-MPS treatment and patients currently on MMF without GI symptoms who will continue with
        MMF therapy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient received kidney transplant at least 1 month prior to study with MMF as a part
             of the treatment for at least 2 weeks.

          -  Eligible to convert to myfortic because of GI complaints or not currently experiencing
             GI complaints and stable on current immunosuppressive regimen.

          -  At least 18 years of age;

          -  Willing to provide written informed consent; and

          -  Able to meet all study requirements including completing paper questionnaires and
             completing two study visits.

        Exclusion Criteria:

          -  GI symptoms assumed or known not be caused by MPA therapy and have recent acute
             rejection at least 1 week prior to the study.

          -  Breast-feeding or pregnant woman.

          -  Patients with psychiatric illness.

          -  Underlying acute medical intervention or hospitalization

          -  Receiving investigational drug within 30days prior to study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universiti Kebangsaan Malaysia</name>
      <address>
        <city>Cheras</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Raja Perempuan Zainab II</name>
      <address>
        <city>Kota Bharu</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Queen Elizabeth</name>
      <address>
        <city>Kota Kinabalu</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Kuala Lumpur</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Tengku Ampuan Afzan</name>
      <address>
        <city>Kuantan</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Umum Sarawak</name>
      <address>
        <city>Kuching</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Pulau Pinang</name>
      <address>
        <city>Pulau Pinang</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Selayang</name>
      <address>
        <city>Selayang</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Serdang</name>
      <address>
        <city>Serdang</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2011</study_first_submitted>
  <study_first_submitted_qc>February 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2011</study_first_posted>
  <last_update_submitted>March 23, 2016</last_update_submitted>
  <last_update_submitted_qc>March 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Kidney transplantation</keyword>
  <keyword>mycophenolate sodium</keyword>
  <keyword>EC-MPS</keyword>
  <keyword>Health Related Quality of Life</keyword>
  <keyword>GI symptoms</keyword>
  <keyword>Immunosuppressants</keyword>
  <keyword>HRQL</keyword>
  <keyword>PGWB</keyword>
  <keyword>GIQLI</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

